Limitations in FABP4 as a biomarker for diabetic nephropathy: a critique of Shaker et al.
Saved in:
Main Authors: | Aimen Waqar Khan (Author), Mishal Abid (Author), Sameer Abdul Rauf (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spontaneous shaker rat mutant - a new model for X-linked tremor/ataxia
by: Karla P. Figueroa, et al.
Published: (2016) -
Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer
by: Naihui Sun, et al.
Published: (2022) -
An overview and critique of the (TVPS-4)
by: Ted Brown, et al.
Published: (2018) -
Characterization of a dual-action adulticidal and larvicidal interfering RNA pesticide targeting the Shaker gene of multiple disease vector mosquitoes.
by: Keshava Mysore, et al.
Published: (2020) -
Pharmacological Inhibition of Fatty Acid-Binding Protein 4 (FABP4) Protects Against Rhabdomyolysis-Induced Acute Kidney Injury
by: Rongshuang Huang, et al.
Published: (2018)